Financial Ratios EssilorLuxottica

Equities

EL

FR0000121667

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 12/02/2026 GMT			After hours 18:18:53
261.30 ^EUR	+4.19%		261.55	+0.10%

05:45pm	European corporate outlook improves, but earnings forecast to fall	RE
04:59pm	European Stock Markets Mixed Ahead of US Inflation Data

1d1209c57fd8e9da908f2e5d0f.eVbATLqH7diUmzbEJbXw4sG5BfSmDcIHkxM9kAcgd84.ABurJPy2wK_txHz1EO3Dja_xc770NalRyXRf-WgUPYUcJvQZ0_2OnsPYBg

Published financial data: ESSILORLUXOTTICA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	14.43B	19.82B	24.49B	25.4B	26.51B
Total Revenues	14.43B	19.82B	24.49B	25.4B	26.51B
Cost of Goods Sold, Total	6.07B	7.71B	9.12B	9.56B	9.93B
Gross Profit	8.36B	12.11B	15.37B	15.83B	16.57B
Selling General & Admin Expenses, Total	7.12B	9.03B	11.55B	12B	12.47B
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	544M	579M	600M	593M	631M
Other Operating Expenses	-3M	-5M	-6M	-21M	-5M
Other Operating Expenses, Total	7.66B	9.6B	12.14B	12.57B	13.09B
Operating Income	694M	2.51B	3.23B	3.26B	3.48B
Interest Expense, Total	-141M	-141M	-156M	-198M	-253M
Interest And Investment Income	24M	30M	30M	87M	97M
Net Interest Expenses	-117M	-111M	-126M	-111M	-156M
Income (Loss) On Equity Invest.	1M	3M	6M	-1M	3M
Currency Exchange Gains (Loss)	-19M	-11M	12M	-7M	20M
Other Non Operating Income (Expenses)	-4M	-7M	-19M	-23M	-24M
EBT, Excl. Unusual Items	555M	2.38B	3.1B	3.12B	3.32B
Restructuring Charges	-172M	-96M	-67M	-96M	-52M
Merger & Related Restructuring Charges	-32M	-65M	-11M	-	-13M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	41M	12M	-
Gain (Loss) On Sale Of Assets	-6M	-2M	9M	-2M	-
Asset Writedown	-25M	-51M	-24M	-	-
Legal Settlements	-	-	-	-	-10M
Other Unusual Items	-7M	34M	-20M	-	42M
EBT, Incl. Unusual Items	313M	2.2B	3.03B	3.04B	3.29B
Income Tax Expense	164M	587M	751M	609M	800M
Earnings From Continuing Operations	149M	1.61B	2.28B	2.43B	2.49B
Net Income to Company	149M	1.61B	2.28B	2.43B	2.49B
Minority Interest	-64M	-150M	-128M	-137M	-132M
Net Income - (IS)	85M	1.46B	2.15B	2.29B	2.36B
Net Income to Common Incl Extra Items	85M	1.46B	2.15B	2.29B	2.36B
Net Income to Common Excl. Extra Items	85M	1.46B	2.15B	2.29B	2.36B
Per Share Items
Net EPS - Basic	0.2	3.33	4.87	5.11	5.2
Basic EPS - Continuing Operations	0.2	3.33	4.87	5.11	5.2
Basic Weighted Average Shares Outstanding	436M	439M	442M	448M	454M
Net EPS - Diluted	0.19	3.28	4.83	5.08	5.13
Diluted EPS - Continuing Operations	0.19	3.28	4.83	5.08	5.13
Diluted Weighted Average Shares Outstanding	439M	445M	446M	451M	460M
Normalized Basic EPS	0.65	3.05	4.1	4.05	4.29
Normalized Diluted EPS	0.64	3	4.06	4.02	4.23
Dividend Per Share	2.23	2.51	3.23	3.95	3.95
Payout Ratio	591.76	9.43	21.1	21.28	49.3
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	2.23B	4.2B	5.23B	5.28B	5.56B
EBITA	1.69B	3.59B	4.53B	4.57B	4.78B
EBIT	694M	2.51B	3.23B	3.26B	3.48B
EBITDAR	2.52B	4.61B	5.78B	5.85B	6.14B
Effective Tax Rate - (Ratio)	52.4	26.68	24.78	20.07	24.31
Total Current Taxes	341M	783M	898M	811M	1.01B
Total Deferred Taxes	-177M	-197M	-147M	-202M	-206M
Normalized Net Income	283M	1.34B	1.81B	1.81B	1.95B
Interest on Long-Term Debt	50M	52M	69M	90M	112M
Non-Cash Pension Expense	6M	-20M	6M	11M	11M
Supplemental Operating Expense Items
Advertising Expense	1.15B	1.46B	1.79B	1.8B	1.82B
Selling and Marketing Expenses	5.43B	7.16B	9.5B	9.84B	10.34B
General and Administrative Expenses	1.7B	1.87B	2.05B	2.16B	2.13B
Research And Development Expense From Footnotes	824M	848M	871M	866M	899M
Net Rental Expense, Total	288M	403M	555M	572M	578M
Imputed Operating Lease Interest Expense	30.49M	36.5M	54.93M	75.94M	94.07M
Imputed Operating Lease Depreciation	258M	367M	500M	496M	484M
Stock-Based Comp., COGS (Total)	-	2M	-	-	-
Stock-Based Comp., S&M Exp. (Total)	-	1M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	28M	5M	-	-	-
Stock-Based Comp., Other (Total)	140M	202M	206M	220M	214M
Total Stock-Based Compensation	168M	210M	206M	220M	214M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	8.68B	3.29B	1.96B	2.56B	2.25B
Short Term Investments	200M	-	-	-	-
Total Cash And Short Term Investments	8.88B	3.29B	1.96B	2.56B	2.25B
Accounts Receivable, Total	2.08B	2.39B	2.73B	2.97B	3.29B
Other Receivables	423M	560M	557M	578M	619M
Total Receivables	2.51B	2.95B	3.29B	3.55B	3.91B
Inventory	1.93B	2.44B	2.79B	2.75B	3.15B
Prepaid Expenses	132M	195M	213M	228M	281M
Other Current Assets, Total	267M	398M	390M	638M	443M
Total Current Assets	13.72B	9.28B	8.64B	9.72B	10.04B
Gross Property Plant And Equipment	8.3B	12.03B	13.16B	13.91B	15.54B
Accumulated Depreciation	-3.2B	-4.89B	-5.41B	-5.66B	-6.36B
Net Property Plant And Equipment	5.1B	7.14B	7.76B	8.25B	9.17B
Long-term Investments	129M	285M	391M	445M	823M
Goodwill	22.66B	29.41B	30.73B	30.26B	32B
Other Intangibles, Total	10.03B	12.29B	12.12B	11.01B	11.05B
Accounts Receivable Long-Term	15M	66M	128M	172M	194M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	418M	498M	408M	387M	391M
Other Long-Term Assets, Total	246M	457M	380M	268M	604M
Total Assets	52.32B	59.43B	60.56B	60.52B	64.26B
Liabilities
Accounts Payable, Total	1.86B	2.22B	2.3B	2.38B	2.66B
Accrued Expenses, Total	1.37B	1.98B	1.88B	1.94B	1.95B
Short-term Borrowings	5M	457M	50M	452M	908M
Current Portion of Long-Term Debt	628M	579M	1.11B	1.41B	1.59B
Current Portion of Leases	527M	837M	846M	841M	914M
Current Income Taxes Payable	530M	805M	229M	245M	231M
Unearned Revenue Current, Total	49M	-	222M	209M	232M
Other Current Liabilities	1.2B	2.06B	2.25B	2.26B	2.07B
Total Current Liabilities	6.17B	8.93B	8.89B	9.74B	10.56B
Long-Term Debt	9.32B	8.91B	7.86B	6.56B	7.07B
Long-Term Leases	1.41B	2.23B	2.34B	2.4B	2.73B
Unearned Revenue Non Current	2M	27M	27M	15M	21M
Pension & Other Post Retirement Benefits	484M	537M	431M	431M	455M
Deferred Tax Liability Non Current	1.89B	2.45B	2.38B	2.14B	2.04B
Other Non Current Liabilities	241M	338M	497M	341M	384M
Total Liabilities	19.52B	23.43B	22.41B	21.63B	23.26B
Common Stock, Total	79M	80M	81M	82M	82M
Additional Paid In Capital	22.01B	22.38B	23.07B	22.88B	23.54B
Retained Earnings	11.96B	12.71B	13.44B	15.38B	15.75B
Treasury Stock	-201M	-231M	-360M	-312M	-172M
Comprehensive Income and Other	-1.58B	246M	1.23B	212M	1.17B
Total Common Equity	32.27B	35.19B	37.46B	38.24B	40.38B
Minority Interest	530M	811M	692M	653M	626M
Total Equity	32.8B	36B	38.15B	38.89B	41B
Total Liabilities And Equity	52.32B	59.43B	60.56B	60.52B	64.26B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	437M	441M	445M	452M	457M
ECS Total Common Shares Outstanding	437M	441M	445M	452M	457M
Book Value / Share	73.84	79.78	84.11	84.59	88.41
Tangible Book Value	-421M	-6.51B	-5.4B	-3.04B	-2.67B
Tangible Book Value Per Share	-0.96	-14.77	-12.13	-6.73	-5.84
Total Debt	11.9B	13.02B	12.2B	11.66B	13.22B
Net Debt	3.01B	9.72B	10.24B	9.1B	10.96B
Debt Equivalent of Unfunded Proj. Benefit Obligation	484M	486M	431M	430M	455M
Debt Equivalent Oper. Leases	2.3B	3.22B	4.44B	4.58B	4.62B
Minority Interest, Total (Incl. Fin. Div)	530M	811M	692M	653M	626M
Equity Method Investments, Total	17M	91M	83M	81M	85M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	555M	676M	790M	780M	868M
Inventories - Work In Process, Total	82M	101M	110M	114M	137M
Inventories - Finished Goods, Total	1.68B	2.13B	2.37B	2.34B	2.7B
Land - (BS)	2.23B	3.19B	3.64B	3.85B	4.48B
Buildings, Total	-	-	-	-	-
Machinery, Total	2.79B	3.76B	4.17B	4.41B	4.93B
Full Time Employees	110K	150K	154K	151K	153K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	134M	220M	180M	166M	186M
Order Backlog	11B	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	85M	1.46B	2.15B	2.29B	2.36B
Depreciation & Amortization - CF	1.11B	1.33B	1.62B	1.64B	1.75B
Amortization of Goodwill and Intangible Assets - (CF)	998M	1.09B	1.3B	1.3B	1.3B
Depreciation & Amortization, Total	2.11B	2.42B	2.92B	2.95B	3.05B
(Gain) Loss From Sale Of Asset	6M	2M	2M	4M	6M
Asset Writedown & Restructuring Costs	25M	42M	49M	25M	49M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	156M	160M	191M	195M	162M
Other Operating Activities, Total	-40M	130M	-176M	-172M	-54M
Change In Accounts Receivable	-	-	-	-159M	-133M
Change in Other Net Operating Assets	610M	329M	-356M	-268M	-564M
Cash from Operations	2.95B	4.54B	4.78B	4.86B	4.87B
Capital Expenditure	-650M	-1.03B	-1.57B	-1.53B	-1.52B
Sale of Property, Plant, and Equipment	8M	16M	17M	11M	10M
Cash Acquisitions	-133M	-7.08B	-965M	-114M	-1.76B
Investment in Marketable and Equity Securities, Total	287M	97M	-184M	-94M	-367M
Other Investing Activities, Total	8M	-65M	85M	4M	12M
Cash from Investing	-480M	-8.06B	-2.62B	-1.72B	-3.62B
Long-Term Debt Issued, Total	2.98B	75M	-	438M	2.38B
Total Debt Issued	2.98B	75M	-	438M	2.38B
Long-Term Debt Repaid, Total	-705M	-1.52B	-1.92B	-1.96B	-2.24B
Total Debt Repaid	-705M	-1.52B	-1.92B	-1.96B	-2.24B
Issuance of Common Stock	36M	34M	37M	34M	35M
Repurchase of Common Stock	-159M	-317M	-431M	-271M	-274M
Common Dividends Paid	-503M	-138M	-454M	-487M	-1.16B
Common & Preferred Stock Dividends Paid	-503M	-138M	-454M	-487M	-1.16B
Other Financing Activities, Total	-152M	-172M	-815M	-175M	-388M
Cash from Financing	1.5B	-2.04B	-3.58B	-2.42B	-1.65B
Foreign Exchange Rate Adjustments	-123M	166M	83M	-114M	88M
Miscellaneous Cash Flow Adjustments	-1M	-	-1M	-	-
Net Change in Cash	3.85B	-5.39B	-1.33B	598M	-307M
Supplemental Items
Cash Income Tax Paid (Refund)	356M	618M	940M	916M	982M
Levered Free Cash Flow	2.87B	3.98B	2.59B	3.23B	3.24B
Unlevered Free Cash Flow	2.95B	4.06B	2.69B	3.36B	3.4B
Change In Net Working Capital	-892M	-898M	885M	318M	521M
Net Debt Issued / Repaid	2.28B	-1.45B	-1.92B	-1.53B	143M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	0.83	2.8	3.37	3.37	3.49
Return on Total Capital	0.97	3.34	4.07	4.04	4.15
Return On Equity %	0.44	4.69	6.16	6.3	6.24
Return on Common Equity	0.25	4.34	5.93	6.05	6
Margin Analysis
Gross Profit Margin %	57.93	61.1	62.77	62.35	62.52
SG&A Margin	49.37	45.56	47.15	47.25	47.03
EBITDA Margin %	15.45	21.21	21.34	20.8	20.98
EBITA Margin %	11.73	18.12	18.5	17.98	18.04
EBIT Margin %	4.81	12.64	13.19	12.85	13.13
Income From Continuing Operations Margin %	1.03	8.14	9.31	9.55	9.4
Net Income Margin %	0.59	7.38	8.79	9.01	8.9
Net Avail. For Common Margin %	0.59	7.38	8.79	9.01	8.9
Normalized Net Income Margin	1.96	6.75	7.4	7.14	7.34
Levered Free Cash Flow Margin	19.87	20.06	10.58	12.73	12.21
Unlevered Free Cash Flow Margin	20.48	20.5	10.98	13.22	12.81
Asset Turnover
Asset Turnover	0.28	0.35	0.41	0.42	0.42
Fixed Assets Turnover	2.69	3.24	3.29	3.17	3.04
Receivables Turnover (Average Receivables)	6.39	8.86	9.57	8.91	8.47
Inventory Turnover (Average Inventory)	2.96	3.52	3.48	3.45	3.37
Short Term Liquidity
Current Ratio	2.22	1.04	0.97	1	0.95
Quick Ratio	1.85	0.7	0.59	0.63	0.58
Operating Cash Flow to Current Liabilities	0.48	0.51	0.54	0.5	0.46
Days Sales Outstanding (Average Receivables)	57.29	41.2	38.16	40.97	43.21
Days Outstanding Inventory (Average Inventory)	123.49	103.56	104.74	105.73	108.72
Average Days Payable Outstanding	113.99	90.57	87.07	89.66	89.2
Cash Conversion Cycle (Average Days)	66.78	54.18	55.83	57.04	62.73
Long Term Solvency
Total Debt/Equity	36.27	36.16	31.99	29.97	32.23
Total Debt / Total Capital	26.61	26.56	24.24	23.06	24.38
LT Debt/Equity	32.73	30.95	26.72	23.03	23.91
Long-Term Debt / Total Capital	24.02	22.73	20.25	17.72	18.08
Total Liabilities / Total Assets	37.31	39.43	37.01	35.74	36.2
EBIT / Interest Expense	4.92	17.77	20.71	16.48	13.76
EBITDA / Interest Expense	19.89	34.93	39.43	31.36	25.81
(EBITDA - Capex) / Interest Expense	15.28	27.62	29.35	23.63	19.79
Total Debt / EBITDA	4.24	2.64	1.98	1.88	2.02
Net Debt / EBITDA	1.07	1.97	1.67	1.47	1.68
Total Debt / (EBITDA - Capex)	5.52	3.34	2.67	2.49	2.64
Net Debt / (EBITDA - Capex)	1.4	2.5	2.24	1.94	2.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-17.03	37.36	23.58	3.68	4.38
Gross Profit, 1 Yr. Growth %	-21.56	50.38	27.51	3.01	4.89
EBITDA, 1 Yr. Growth %	-37.88	107.66	33.1	3.31	7.48
EBITA, 1 Yr. Growth %	-45.12	144.85	35.16	3.4	7.17
EBIT, 1 Yr. Growth %	-65.93	464.41	43.75	4.75	10.26
Earnings From Cont. Operations, 1 Yr. Growth %	-87.43	982.55	42.68	6.4	2.68
Net Income, 1 Yr. Growth %	-92.11	1.62K	48.62	6.37	3.06
Normalized Net Income, 1 Yr. Growth %	-73.7	956.27	54.16	4.26	11.34
Diluted EPS Before Extra, 1 Yr. Growth %	-92.21	1.63K	48.62	5.18	0.98
Accounts Receivable, 1 Yr. Growth %	-14.27	14.58	14.36	8.67	10.81
Inventory, 1 Yr. Growth %	-10.9	26.68	14.07	-1.4	14.62
Net Property, Plant and Equip., 1 Yr. Growth %	-9.46	39.99	8.63	6.37	11.17
Total Assets, 1 Yr. Growth %	-0.5	13.59	1.93	-0.06	6.18
Tangible Book Value, 1 Yr. Growth %	-27.16	1.45K	-18.65	-43.71	-12.27
Common Equity, 1 Yr. Growth %	-7.27	9.05	6.82	2.09	5.59
Cash From Operations, 1 Yr. Growth %	-10.49	53.91	5.24	1.63	0.27
Capital Expenditures, 1 Yr. Growth %	-28.02	58.46	52.62	-2.61	-0.59
Levered Free Cash Flow, 1 Yr. Growth %	141.65	44.37	-31.65	28.35	2.21
Unlevered Free Cash Flow, 1 Yr. Growth %	128.5	43	-30.69	28.3	3.18
Dividend Per Share, 1 Yr. Growth %	-	12.56	28.69	22.29	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.41	6.76	30.29	13.19	4.03
Gross Profit, 2 Yr. CAGR %	11.35	6.6	38.17	14.6	3.84
EBITDA, 2 Yr. CAGR %	-0.84	8.2	60.7	15.97	4.31
EBITA, 2 Yr. CAGR %	-6.17	7.94	75.76	16.71	4.04
EBIT, 2 Yr. CAGR %	-32.25	10.92	169.72	20.51	5.71
Earnings From Cont. Operations, 2 Yr. CAGR %	-64	16.67	291.18	23.21	4.52
Net Income, 2 Yr. CAGR %	-71.98	16.55	403.17	25.73	4.7
Normalized Net Income, 2 Yr. CAGR %	-40.88	11.5	278.22	24.24	5.76
Diluted EPS Before Extra, 2 Yr. CAGR %	-78.39	15.94	404.19	25.02	3.06
Accounts Receivable, 2 Yr. CAGR %	-6.07	-0.89	14.47	11.48	9.74
Inventory, 2 Yr. CAGR %	-2.59	6.25	20.21	6.05	6.31
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.64	12.58	23.32	7.49	8.74
Total Assets, 2 Yr. CAGR %	3.97	6.31	7.59	0.93	3.01
Tangible Book Value, 2 Yr. CAGR %	-59.46	235.71	258.18	-32.33	-29.73
Common Equity, 2 Yr. CAGR %	-0.96	0.56	7.74	4.43	3.83
Cash From Operations, 2 Yr. CAGR %	11.88	17.38	27.27	3.42	0.95
Capital Expenditures, 2 Yr. CAGR %	-4.32	6.8	55.51	21.92	-1.6
Levered Free Cash Flow, 2 Yr. CAGR %	12.72	83.06	-2.99	-7.65	13.36
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.61	77.26	-2.72	-6.97	13.91
Dividend Per Share, 2 Yr. CAGR %	4.55	-	20.35	25.45	10.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.25	22.31	12.1	20.74	10.18
Gross Profit, 3 Yr. CAGR %	12.59	21.56	12.99	25.28	11.19
EBITDA, 3 Yr. CAGR %	0.24	22.83	13.34	37.67	12.3
EBITA, 3 Yr. CAGR %	-3.86	23.18	13.7	46.02	12.55
EBIT, 3 Yr. CAGR %	-25.42	18.34	16.61	94.42	15.71
Earnings From Cont. Operations, 3 Yr. CAGR %	-47.71	11.94	24.38	153.46	15.95
Net Income, 3 Yr. CAGR %	-56.6	10.54	25.95	199.74	17.67
Normalized Net Income, 3 Yr. CAGR %	-34.1	18.23	18.97	142.85	18.3
Diluted EPS Before Extra, 3 Yr. CAGR %	-65.7	-6.94	25.56	199.02	16.43
Accounts Receivable, 3 Yr. CAGR %	30	0.37	3.95	12.5	11.26
Inventory, 3 Yr. CAGR %	32.38	6.33	8.79	12.53	8.84
Net Property, Plant and Equip., 3 Yr. CAGR %	41.28	11.39	11.25	17.39	8.71
Total Assets, 3 Yr. CAGR %	73.23	7.08	4.82	4.98	2.65
Tangible Book Value, 3 Yr. CAGR %	-23.87	36.49	110.63	93.28	-26.21
Common Equity, 3 Yr. CAGR %	77.11	2.27	2.48	5.82	4.81
Cash From Operations, 3 Yr. CAGR %	22.59	24.43	13.18	18.07	2.36
Capital Expenditures, 3 Yr. CAGR %	-0.71	13.2	20.3	33.05	13.9
Levered Free Cash Flow, 3 Yr. CAGR %	32.08	20.78	29.75	5.51	-5.13
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.43	20.37	27.64	5.72	-4.34
Dividend Per Share, 3 Yr. CAGR %	13.38	7.16	-	20.99	16.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.53	22.74	21.68	18.58	8.8
Gross Profit, 5 Yr. CAGR %	15.81	23.7	21.29	18.62	9.23
EBITDA, 5 Yr. CAGR %	6.71	19.66	18.74	18.42	9.15
EBITA, 5 Yr. CAGR %	4.03	19.24	18.94	18.9	9.17
EBIT, 5 Yr. CAGR %	-10.6	14.49	14.06	16.63	11.31
Earnings From Cont. Operations, 5 Yr. CAGR %	-28.78	12.88	16.95	16.1	16.02
Net Income, 5 Yr. CAGR %	-35.42	12.47	15.65	16.15	16.98
Normalized Net Income, 5 Yr. CAGR %	-15.7	14.2	12.87	17.51	12.58
Diluted EPS Before Extra, 5 Yr. CAGR %	-44.16	-2.43	0.5	4.53	16.02
Accounts Receivable, 5 Yr. CAGR %	7.45	8.11	23.55	4.67	6.23
Inventory, 5 Yr. CAGR %	11.92	16.8	27.37	6.22	7.79
Net Property, Plant and Equip., 5 Yr. CAGR %	33.57	42.53	33.8	9.81	10.24
Total Assets, 5 Yr. CAGR %	34.31	35.18	43.18	4.57	4.09
Tangible Book Value, 5 Yr. CAGR %	-21.52	37.45	41.44	3.48	35.77
Common Equity, 5 Yr. CAGR %	41.41	39.39	45.18	3.05	3.02
Cash From Operations, 5 Yr. CAGR %	19.85	30.65	24.44	15.56	8.12
Capital Expenditures, 5 Yr. CAGR %	14.73	28.5	18.81	16.61	11.01
Levered Free Cash Flow, 5 Yr. CAGR %	31.86	30.07	15.81	7.46	22.24
Unlevered Free Cash Flow, 5 Yr. CAGR %	31.09	29.58	15.61	7.58	21.3
Dividend Per Share, 5 Yr. CAGR %	14.97	10.85	16.12	14.13	-